Professor Greg Shaw, the trial lead from UCL Surgery & Interventional Science and Consultant Urologist at UCLH, said, "Our results show that, by using NeuroSAFE, nearly twice as many men don't have to ...

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...

The myth is that prostate cancer treatment destroys men’s erections. The truth is more complicated. Men facing treatment for this disease should prepare themselves emotionally for permanent erectile ...

The journey through prostate cancer treatment marks a significant chapter in many men’s lives, with surgery often serving as a pivotal turning point toward recovery. While the removal of cancerous ...

Receiving radiotherapy after prostatectomy does negatively affect long-term health-related quality of life, including sexual function, urinary incontinence, and urinary irritation, but the timing of ...

When a man receives a prostate cancer diagnosis, thoughts often race toward treatment options and survival rates. However, the recovery journey after prostate surgery represents a critical chapter ...

Twelve months after surgery, 39% of men in the NeuroSAFE arm had no or mild erectile dysfunction 3. In those men who had standard surgery this was 23%. A year after their operation, only 38% of those ...

Localized prostate cancer treatments include radical prostatectomy and focal therapy, with the latter targeting only cancerous areas to preserve healthy tissue. Focal therapy allows for active ...

Twelve months after surgery, 39% of men in the NeuroSAFE arm had no or mild erectile dysfunction 3. In those men who had standard surgery this was 23%. A year after their operation, only 38% of those ...